Literature DB >> 27061054

The BDLF3 gene product of Epstein-Barr virus, gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection.

Liudmila S Chesnokova1, Sarah M Valencia2, Lindsey M Hutt-Fletcher3.   

Abstract

The cell surface molecules used by Epstein-Barr virus (EBV) to attach to epithelial cells are not well-defined, although when CD21, the B cell receptor for EBV is expressed epithelial cell infection increases disproportionately to the increase in virus bound. Many herpesviruses use low affinity charge interactions with molecules such as heparan sulfate to attach to cells. We report here that the EBV glycoprotein gp150 binds to heparan sulfate proteoglycans, but that attachment via this glycoprotein is not productive of infection. We also report that only the aminoterminal two short consensus repeats of CD21 are required for efficient infection, This supports the hypothesis that, when expressed on an epithelial cell CD21 serves primarily to cluster the major attachment protein gp350 in the virus membrane and enhance access of other important glycoproteins to the epithelial cell surface.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD21; Epithelial cell infection; Epstein-Barr virus; Glycoprotein 150; Heparan-binding

Mesh:

Substances:

Year:  2016        PMID: 27061054      PMCID: PMC4884462          DOI: 10.1016/j.virol.2016.04.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  53 in total

1.  Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.

Authors:  K M Haan; W W Kwok; R Longnecker; P Speck
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Authors:  A Janz; M Oezel; C Kurzeder; J Mautner; D Pich; M Kost; W Hammerschmidt; H J Delecluse
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells.

Authors:  T Oda; S Imai; S Chiba; K Takada
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

4.  Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.

Authors:  Rachel M Temple; Junjia Zhu; Lynn Budgeon; Neil David Christensen; Craig Meyers; Clare E Sample
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

5.  Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.

Authors:  Javier G Ogembo; Lakshmi Kannan; Ionita Ghiran; Anne Nicholson-Weller; Robert W Finberg; George C Tsokos; Joyce D Fingeroth
Journal:  Cell Rep       Date:  2013-02-14       Impact factor: 9.423

6.  Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.

Authors:  D M Walling; C M Flaitz; C M Nichols; S D Hudnall; K Adler-Storthz
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

7.  Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells.

Authors:  S J Molesworth; C M Lake; C M Borza; S M Turk; L M Hutt-Fletcher
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Comparison of SYBR Green and TaqMan real-time PCR methods for quantitative detection of residual CHO host-cell DNA in biopharmaceuticals.

Authors:  Mohammad Soltany-Rezaee-Rad; Zargham Sepehrizadeh; Negar Mottaghi-Dastjerdi; Mojtaba Tabatabaei Yazdi; Neda Seyatesh
Journal:  Biologicals       Date:  2014-12-04       Impact factor: 1.856

Review 9.  Interaction of KSHV with host cell surface receptors and cell entry.

Authors:  Mohanan Valiya Veettil; Chirosree Bandyopadhyay; Dipanjan Dutta; Bala Chandran
Journal:  Viruses       Date:  2014-10-23       Impact factor: 5.048

10.  EBV infection is common in gingival epithelial cells of the periodontium and worsens during chronic periodontitis.

Authors:  Séverine Vincent-Bugnas; Sébastien Vitale; Caroline C Mouline; Wafa Khaali; Yves Charbit; Patrick Mahler; Isabelle Prêcheur; Paul Hofman; Janet L Maryanski; Alain Doglio
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more
  5 in total

1.  The Major Envelope Glycoprotein of Murid Herpesvirus 4 Promotes Sexual Transmission.

Authors:  Caroline Zeippen; Justine Javaux; Xue Xiao; Marina Ledecq; Jan Mast; Frédéric Farnir; Alain Vanderplasschen; Philip Stevenson; Laurent Gillet
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 2.  Is heparan sulfate a target for inhibition of RNA virus infection?

Authors:  Jiaxin Ling; Jinlin Li; Asifa Khan; Åke Lundkvist; Jin-Ping Li
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-23       Impact factor: 4.249

3.  Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective.

Authors:  Gabriela M Escalante; Lorraine Z Mutsvunguma; Murali Muniraju; Esther Rodriguez; Javier Gordon Ogembo
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

4.  IFITM1 expression is crucial to gammaherpesvirus infection, in vivo.

Authors:  Hosni A M Hussein; Katarina Briestenska; Jela Mistrikova; Shaw M Akula
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

5.  A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells.

Authors:  Ina Ersing; Luis Nobre; Liang Wei Wang; Lior Soday; Yijie Ma; Joao A Paulo; Yohei Narita; Camille W Ashbaugh; Chang Jiang; Nicholas E Grayson; Elliott Kieff; Steven P Gygi; Michael P Weekes; Benjamin E Gewurz
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.